Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenografts

Translational Oncology

Volumn 3, Issue 3, 2010, Pages 149-152

  Zielske, Steven P ^a   Spalding, Aaron C ^a   Lawrence, Theodore S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; CD44V ANTIGEN; CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER CONTROL; CANCER STEM CELL; CARCINOGENESIS; CELL ACTIVITY; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVITY; FUNCTIONAL ASSESSMENT; MOUSE; NONHUMAN; PHENOTYPE; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 77954671617     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.09307     Document Type: Article

References (12)

1. Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K, and Mori M (2008). Cancer stem cells and cliemoradiation resistance. Cancer Sci 99, 1871-1877.
2. Dontu G, Liu S, and Wiclia MS (2005). Stem cells in mammary development and carcinogenesis: implications for prevention and treatment. Stem Cell Rev 1, 207-213.
3. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Cliamness GC, et al. (2008). Intrinsic resistance of tumor-igenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100, 672-679.
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, and Clarke MF (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-3988.
5. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567.
6. Beier D, Rohrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, et al. (2008). Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 68, 5706-5715.
7. + glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res 15, 5145-5153.
8. Russo JE and Hilton J (1988). Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res 48, 2963-2968.
9. Takebe N, Zhao SC, Adhikari D, Mineishi S, Sadelain M, Hilton J, Colvin M, Banerjee D, and Bertino JR (2001). Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Mol Ther 3, 88-96.
10. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S, et al. (2008). Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 3, e2428.
11. Levi BP, Yilmaz OH, Duester G, and Morrison SJ (2009). Aldehyde dehydrogenase lal is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 113, 1670-1680.
12. Tan S, Chen JS, Sun LJ, and Yao HR (2009). Selective enrichment of hepatocellular cancer stem cells by chemotherapy.J Int Med Res 37, 1046-1056.